Clinical Trials Logo

Postpartum Contraception clinical trials

View clinical trials related to Postpartum Contraception.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02866643 Completed - Family Planning Clinical Trials

Labor and Delivery Implant Insertion: A Randomized Controlled Trial

LADII
Start date: October 28, 2016
Phase: Phase 3
Study type: Interventional

A barrier to initiating progestin contraceptives in the early postpartum period is the concern of interference with breastfeeding, specifically lactogenesis. In this trial, the investigators aim to describe the effects of immediate insertion of the contraceptive implant on breastfeeding. The investigators seek to examine the time to lactogenesis with immediate post-delivery insertion in delivery room versus insertion of a contraceptive implant in the postpartum ward prior to medical discharge. For this study, 82 consenting women will be randomized to immediate implant insertion (0-2 hours following delivery) in the delivery room or insertion of the implant following delivery in postpartum room and prior to medical discharge (24-48 hours following delivery). Participants complete a questionnaire that asks questions about breastfeeding continuation, supplementation, duration, and exclusivity. This questionnaire also includes questions about contraceptive continuation, patient satisfaction with implant, pregnancy, and postpartum care visits.

NCT ID: NCT02866279 Completed - Contraception Clinical Trials

Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial

Start date: November 2016
Phase: N/A
Study type: Interventional

The investigators goal is to measure the impact of timing of postpartum contraceptive implant insertion on breastfeeding success and duration and to explore women's experiences with and attitudes towards contraceptive and breastfeeding counseling in the peripartum time period

NCT ID: NCT01555931 Completed - Clinical trials for Postpartum Contraception

Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding

PPIUD1
Start date: March 2012
Phase: Phase 4
Study type: Interventional

This will be a randomized clinical trial of 190 women aged 18-45 who plan to breastfeed their infant for at least 6 months and desire to use the LNG-IUS as their primary contraceptive method postpartum. The investigators will compare the frequency of breastfeeding among women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) immediately after vaginal delivery compared to 4-8 weeks later. The investigators hypothesize there will be no difference in breastfeeding prevalence between the two groups.